Tisha Guzman - Executive Coordinator to the Chairman & CEO
Executive Coordinator at Gilead Sciences · Experience: Gilead Sciences · Location: Danville · 224 connections on LinkedIn. View Tisha Guzman’s profile on LinkedIn, a professional …
- 职位: Executive Coordinator at …
- 位置: Gilead Sciences
- 人脉数: 224
Daniel O’Day | Gilead
Mr. O’Day joined Gilead in March 2019 as Chairman of the Board of Directors and Chief Executive Officer. Prior to Gilead, Mr. O’Day served as the Chief Executive Officer of Roche …
Daniel O'Day - Board Member - Georgetown University - LinkedIn
View Daniel O'Day’s profile on LinkedIn, a professional community of 1 billion members. Chairman and Chief Executive Officer at Gilead Sciences · Working with Gilead employees …
- 职位: Chairman and Chief Executive …
- 位置: Georgetown University
Daniel O’Day – PhRMA China
Daniel O’Day于2019年3月出任吉利德科学董事会主席兼首席执行官。 加入吉利德之前，Daniel O’Day先生曾在罗氏制药担任首席执行官。 他在罗氏（Roche Pharmaceuticals）任职超过三 …
Daniel O'Day - Galapagos
Daniel O’Day is a non-executive member of Galapagos’ Board of Directors since 22 October 2019. Mr. O’Day is the Chairman of the Board of Directors and Chief Executive Officer of …
210亿美元，吉利德天价收购的背后 - 新浪科技
2020年9月17日 · 在吉利德轰轰烈烈的人事革新下，Daniel O'Day 带领吉利德新的业务负责人聚焦打破产品管线主要集中在抗病毒领域的单一局面，同时围绕抗病毒、炎症 ...
Gilead Sciences snares Roche veteran O'Day as CEO | Reuters
2018年12月10日 · Drugmaker Gilead Sciences Inc <GILD.O> on Monday named Roche Holding AG's <ROG.S> Daniel O'Day as its new chief executive, tapping an industry veteran to fill a …
New Gilead chief plots Kite CEO hire, pipeline M&A and …
2019年5月3日 · Gilead Sciences tapped new CEO Daniel O’Day in part because of his cancer expertise. But he’s not planning to lead the company’s oncology ramp-up alone. The Roche …
Daniel O’Day - Irish America
Daniel O’Day joined Gilead Sciences in 2019 as chairman of the board and CEO. Prior to Gilead, Daniel served as the CEO of Roche Pharmaceuticals. His career at Roche spanned more than …
吉利德科学CEO丹尼尔·奥戴当选PhRMA董事会主席
美国东部时间2024年2月21日，美国药品研究与制造企业协会（PhRMA）宣布，吉利德科学公司董事长兼首席执行官丹尼尔·奥戴（Daniel O’Day）正式出任 PhRMA 董事会主席。